Global NK Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global NK Cell Therapy market is projected to reach US$ 1006.7 million by 2028 from an estimated US$ 408.9 million in 2022, at a CAGR of 16.2% during 2023 and 2028.

North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.

The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Nektar Therapeutics

Innate Pharma SA

Affimed

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

NantWorks

Nkarta Therapeutics

Fortress Biotech

Product Type Insights

Global markets are presented by NK Cell Therapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the NK Cell Therapy are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

NK Cell Therapies

NK Cell Directed Antibodies

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the NK Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the NK Cell Therapy market.

Cancer

Gastrointestinal Diseases

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the NK Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of NK Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the NK Cell Therapy industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Therapy.

1.1 NK Cell Therapy Product Introduction

1.2 Market by Type

1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global NK Cell Therapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global NK Cell Therapy Market Size Estimates and Forecasts

2.2 NK Cell Therapy Market Size by Region: 2022 Versus 2028

2.2.1 Global NK Cell Therapy Revenue by Region: 2017-2022

2.2.2 Global NK Cell Therapy Revenue Forecast by Region (2023-2028)

2.2.3 Global NK Cell Therapy Revenue Market Share by Region (2017-2028)

3.1 Global NK Cell Therapy Revenue by Company (2017-2022)

3.2 Global NK Cell Therapy Revenue Share by Company (2017-2022)

3.3 Competitive Landscape

3.3.1 Key NK Cell Therapy Companies around the World: Ranking by Revenue

3.3.2 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.3.3 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global NK Cell Therapy Companies Headquarters & Product Type

3.4.1 NK Cell Therapy Companies Headquarters

3.4.2 Global NK Cell Therapy Companies Product & Service

3.4.3 Date of International Companies Enter into NK Cell Therapy Market

3.5 Global NK Cell Therapy Mergers & Acquisitions, Expansion Plans

4.1 Nektar Therapeutics

4.1.1 Nektar Therapeutics Corporation Information

4.1.2 Nektar Therapeutics Description, Business Overview

4.1.3 Nektar Therapeutics NK Cell Therapy Products Offered

4.1.4 Nektar Therapeutics NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.1.5 Nektar Therapeutics NK Cell Therapy Revenue by Product in 2021

4.1.6 Nektar Therapeutics NK Cell Therapy Revenue by Application in 2021

4.1.7 Nektar Therapeutics NK Cell Therapy Revenue by Geographic Area in 2021

4.1.8 Nektar Therapeutics Recent Developments

4.2 Innate Pharma SA

4.2.1 Innate Pharma SA Corporation Information

4.2.2 Innate Pharma SA Description, Business Overview

4.2.3 Innate Pharma SA NK Cell Therapy Products Offered

4.2.4 Innate Pharma SA NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.2.5 Innate Pharma SA NK Cell Therapy Revenue by Product in 2021

4.2.6 Innate Pharma SA NK Cell Therapy Revenue by Application in 2021

4.2.7 Innate Pharma SA NK Cell Therapy Revenue by Geographic Area in 2021

4.2.8 Innate Pharma SA Recent Developments

4.3 Affimed

4.3.1 Affimed Corporation Information

4.3.2 Affimed Description, Business Overview

4.3.3 Affimed NK Cell Therapy Products Offered

4.3.4 Affimed NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.3.5 Affimed NK Cell Therapy Revenue by Product in 2021

4.3.6 Affimed NK Cell Therapy Revenue by Application in 2021

4.3.7 Affimed NK Cell Therapy Revenue by Geographic Area in 2021

4.3.8 Affimed Recent Developments

4.4 Chipscreen Biosciences

4.4.1 Chipscreen Biosciences Corporation Information

4.4.2 Chipscreen Biosciences Description, Business Overview

4.4.3 Chipscreen Biosciences NK Cell Therapy Products Offered

4.4.4 Chipscreen Biosciences NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.4.5 Chipscreen Biosciences NK Cell Therapy Revenue by Product in 2021

4.4.6 Chipscreen Biosciences NK Cell Therapy Revenue by Application in 2021

4.4.7 Chipscreen Biosciences NK Cell Therapy Revenue by Geographic Area in 2021

4.4.8 Chipscreen Biosciences Recent Developments

4.5 Fate Therapeutics

4.5.1 Fate Therapeutics Corporation Information

4.5.2 Fate Therapeutics Description, Business Overview

4.5.3 Fate Therapeutics NK Cell Therapy Products Offered

4.5.4 Fate Therapeutics NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.5.5 Fate Therapeutics NK Cell Therapy Revenue by Product in 2021

4.5.6 Fate Therapeutics NK Cell Therapy Revenue by Application in 2021

4.5.7 Fate Therapeutics NK Cell Therapy Revenue by Geographic Area in 2021

4.5.8 Fate Therapeutics Recent Developments

4.6 Glycostem Therapeutics

4.6.1 Glycostem Therapeutics Corporation Information

4.6.2 Glycostem Therapeutics Description, Business Overview

4.6.3 Glycostem Therapeutics NK Cell Therapy Products Offered

4.6.4 Glycostem Therapeutics NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.6.5 Glycostem Therapeutics NK Cell Therapy Revenue by Product in 2021

4.6.6 Glycostem Therapeutics NK Cell Therapy Revenue by Application in 2021

4.6.7 Glycostem Therapeutics NK Cell Therapy Revenue by Geographic Area in 2021

4.6.8 Glycostem Therapeutics Recent Development

4.7 Dragonfly Therapeutics

4.7.1 Dragonfly Therapeutics Corporation Information

4.7.2 Dragonfly Therapeutics Description, Business Overview

4.7.3 Dragonfly Therapeutics NK Cell Therapy Products Offered

4.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.7.5 Dragonfly Therapeutics NK Cell Therapy Revenue by Product in 2021

4.7.6 Dragonfly Therapeutics NK Cell Therapy Revenue by Application in 2021

4.7.7 Dragonfly Therapeutics NK Cell Therapy Revenue by Geographic Area in 2021

4.7.8 Dragonfly Therapeutics Recent Development

4.8 Kiadis Pharma

4.8.1 Kiadis Pharma Corporation Information

4.8.2 Kiadis Pharma Description, Business Overview

4.8.3 Kiadis Pharma NK Cell Therapy Products Offered

4.8.4 Kiadis Pharma NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.8.5 Kiadis Pharma NK Cell Therapy Revenue by Product in 2021

4.8.6 Kiadis Pharma NK Cell Therapy Revenue by Application in 2021

4.8.7 Kiadis Pharma NK Cell Therapy Revenue by Geographic Area in 2021

4.8.8 Kiadis Pharma Recent Development

4.9 NantWorks

4.9.1 NantWorks Corporation Information

4.9.2 NantWorks Description, Business Overview

4.9.3 NantWorks NK Cell Therapy Products Offered

4.9.4 NantWorks NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.9.5 NantWorks NK Cell Therapy Revenue by Product in 2021

4.9.6 NantWorks NK Cell Therapy Revenue by Application in 2021

4.9.7 NantWorks NK Cell Therapy Revenue by Geographic Area in 2021

4.9.8 NantWorks Recent Development

4.10 Nkarta Therapeutics

4.10.1 Nkarta Therapeutics Corporation Information

4.10.2 Nkarta Therapeutics Description, Business Overview

4.10.3 Nkarta Therapeutics NK Cell Therapy Products Offered

4.10.4 Nkarta Therapeutics NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.10.5 Nkarta Therapeutics NK Cell Therapy Revenue by Product in 2021

4.10.6 Nkarta Therapeutics NK Cell Therapy Revenue by Application in 2021

4.10.7 Nkarta Therapeutics NK Cell Therapy Revenue by Geographic Area in 2021

4.10.8 Nkarta Therapeutics Recent Development

4.11 Fortress Biotech

4.11.1 Fortress Biotech Corporation Information

4.11.2 Fortress Biotech Description, Business Overview

4.11.3 Fortress Biotech NK Cell Therapy Products Offered

4.11.4 Fortress Biotech NK Cell Therapy Revenue and Gross Margin (2017-2022)

4.11.5 Fortress Biotech NK Cell Therapy Revenue by Product in 2021

4.11.6 Fortress Biotech NK Cell Therapy Revenue by Application in 2021

4.11.7 Fortress Biotech NK Cell Therapy Revenue by Geographic Area in 2021

4.11.8 Fortress Biotech Recent Development

5.1 Global NK Cell Therapy Revenue by Type (2017-2022)

5.2 Global NK Cell Therapy Revenue Forecast by Type (2023-2028)

5.3 NK Cell Therapy Revenue Marke Share by Type (2017-2028)

6.1 Global NK Cell Therapy Revenue by Application (2017-2022)

6.2 Global NK Cell Therapy Revenue Forecast by Application (2023-2028)

6.3 NK Cell Therapy Revenue Market Share by Application (2017-2028)

7.1 North America NK Cell Therapy Market Size YoY Growth 2017-2028

7.2 North America NK Cell Therapy Market Facts & Figures by Country (2017-2028)

7.3 North America NK Cell Therapy Revenue by Type (2017-2022)

7.4 North America NK Cell Therapy Revenue by Application (2017-2022)

8.1 Asia-Pacific NK Cell Therapy Market Size YoY Growth 2017-2028

8.2 Asia-Pacific NK Cell Therapy Market Facts & Figures by Region (2017-2028)

8.3 Asia-Pacific NK Cell Therapy Revenue by Type (2017-2022)

8.4 Asia-Pacific NK Cell Therapy Revenue by Application (2017-2022)

9.1 Europe NK Cell Therapy Market Size YoY Growth 2017-2028

9.2 Europe NK Cell Therapy Market Facts & Figures by Country (2017-2028)

9.3 Europe NK Cell Therapy Revenue by Type (2017-2022)

9.4 Europe NK Cell Therapy Revenue by Application (2017-2022)

10.1 Latin America NK Cell Therapy Market Size YoY Growth 2017-2028

10.2 Latin America NK Cell Therapy Market Facts & Figures by Country (2017-2028)

10.3 Latin America NK Cell Therapy Revenue by Type (2017-2022)

10.4 Latin America NK Cell Therapy Revenue by Application (2017-2022)

11.1 Middle East and Africa NK Cell Therapy Market Size YoY Growth 2017-2028

11.2 Middle East and Africa NK Cell Therapy Market Facts & Figures by Country (2017-2028)

11.3 Middle East and Africa NK Cell Therapy Revenue by Type (2017-2022)

11.4 Middle East and Africa NK Cell Therapy Revenue by Application (2017-2022)

12.1 NK Cell Therapy Supply Chain Analysis

12.2 NK Cell Therapy Key Raw Materials and Upstream Suppliers

12.3 NK Cell Therapy Clients Analysis

12.4 NK Cell Therapy Sales Channel and Sales Model Analysis

12.4.1 NK Cell Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 NK Cell Therapy Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 NK Cell Therapy Distributors

13.1 NK Cell Therapy Industry Trends

13.2 NK Cell Therapy Market Drivers

13.3 NK Cell Therapy Market Challenges

13.4 NK Cell Therapy Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Companies of NK Cell Therapies

    Table 3. Major Companies of NK Cell Directed Antibodies

    Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2022 VS 2028

    Table 6. Global NK Cell Therapy Revenue by Region (2017-2022) & (US$ Million)

    Table 7. Global NK Cell Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 8. NK Cell Therapy Revenue by Company (2017-2022) & (US$ Million)

    Table 9. NK Cell Therapy Revenue Share by Company (2017-2022)

    Table 10. Ranking of Global Top NK Cell Therapy Players by Revenue (US$ Million) in 2021

    Table 11. Global NK Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 12. Global NK Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2021)

    Table 13. Global NK Cell Therapy Companies Headquarters

    Table 14. Global NK Cell Therapy Companies Product & Service

    Table 15. Date of International Companies Enter into NK Cell Therapy Market

    Table 16. Global NK Cell Therapy Mergers & Acquisitions, Expansion Plans

    Table 17. Nektar Therapeutics Corporation Information

    Table 18. Nektar Therapeutics Description and Business Overview

    Table 19. Nektar Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 20. Nektar Therapeutics NK Cell Therapy Product

    Table 21. Nektar Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 22. Nektar Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 23. Nektar Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 24. Nektar Therapeutics Recent Development

    Table 25. Innate Pharma SA Corporation Information

    Table 26. Innate Pharma SA Description and Business Overview

    Table 27. Innate Pharma SA NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 28. Innate Pharma SA NK Cell Therapy Product

    Table 29. Innate Pharma SA NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 30. Innate Pharma SA NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 31. Innate Pharma SA NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 32. Innate Pharma SA Recent Development

    Table 33. Affimed Corporation Information

    Table 34. Affimed Description and Business Overview

    Table 35. Affimed NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 36. Affimed NK Cell Therapy Product

    Table 37. Affimed NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 38. Affimed NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 39. Affimed NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 40. Affimed Recent Development

    Table 41. Chipscreen Biosciences Corporation Information

    Table 42. Chipscreen Biosciences Description and Business Overview

    Table 43. Chipscreen Biosciences NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 44. Chipscreen Biosciences NK Cell Therapy Product

    Table 45. Chipscreen Biosciences NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 46. Chipscreen Biosciences NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 47. Chipscreen Biosciences NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 48. Chipscreen Biosciences Recent Development

    Table 49. Fate Therapeutics Corporation Information

    Table 50. Fate Therapeutics Description and Business Overview

    Table 51. Fate Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 52. Fate Therapeutics NK Cell Therapy Product

    Table 53. Fate Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 54. Fate Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 55. Fate Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 56. Fate Therapeutics Recent Development

    Table 57. Glycostem Therapeutics Corporation Information

    Table 58. Glycostem Therapeutics Description and Business Overview

    Table 59. Glycostem Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 60. Glycostem Therapeutics NK Cell Therapy Product

    Table 61. Glycostem Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 62. Glycostem Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 63. Glycostem Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 64. Dragonfly Therapeutics Corporation Information

    Table 65. Dragonfly Therapeutics Description and Business Overview

    Table 66. Dragonfly Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 67. Dragonfly Therapeutics NK Cell Therapy Product

    Table 68. Dragonfly Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 69. Dragonfly Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 70. Dragonfly Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 71. Kiadis Pharma Corporation Information

    Table 72. Kiadis Pharma Description and Business Overview

    Table 73. Kiadis Pharma NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 74. Kiadis Pharma NK Cell Therapy Product

    Table 75. Kiadis Pharma NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 76. Kiadis Pharma NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 77. Kiadis Pharma NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 78. NantWorks Corporation Information

    Table 79. NantWorks Description and Business Overview

    Table 80. NantWorks NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 81. NantWorks NK Cell Therapy Product

    Table 82. NantWorks NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 83. NantWorks NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 84. NantWorks NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 85. Nkarta Therapeutics Corporation Information

    Table 86. Nkarta Therapeutics Description and Business Overview

    Table 87. Nkarta Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 88. Nkarta Therapeutics NK Cell Therapy Product

    Table 89. Nkarta Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 90. Nkarta Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 91. Nkarta Therapeutics NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 92. Fortress Biotech Corporation Information

    Table 93. Fortress Biotech Description and Business Overview

    Table 94. Fortress Biotech NK Cell Therapy Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 95. Fortress Biotech NK Cell Therapy Product

    Table 96. Fortress Biotech NK Cell Therapy Revenue Proportion of NK Cell Therapy by Product in 2021

    Table 97. Fortress Biotech NK Cell Therapy Revenue Proportion of NK Cell Therapy by Application in 2021

    Table 98. Fortress Biotech NK Cell Therapy Revenue Proportion of NK Cell Therapy by Geographic Area in 2021

    Table 99. Global NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 100. Global NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 101. Global NK Cell Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 102. North America NK Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 103. North America NK Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 104. North America NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 105. North America NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 106. Asia-Pacific NK Cell Therapy Revenue by Region (2017-2028) & (US$ Million)

    Table 107. Asia-Pacific NK Cell Therapy Revenue by Region (2023-2028) & (US$ Million)

    Table 108. Asia-Pacific NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 109. Asia-Pacific NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 110. Europe NK Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 111. Europe NK Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 112. Europe NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 113. Europe NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 114. Latin America NK Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 115. Latin America NK Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 116. Latin America NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 117. Latin America NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 118. Middle East and Africa NK Cell Therapy Revenue by Country (2017-2022) & (US$ Million)

    Table 119. Middle East and Africa NK Cell Therapy Revenue by Country (2023-2028) & (US$ Million)

    Table 120. Middle East and Africa NK Cell Therapy Revenue by Type (2017-2022) & (US$ Million)

    Table 121. Middle East and Africa NK Cell Therapy Revenue by Application (2017-2022) & (US$ Million)

    Table 122. NK Cell Therapy Key Raw Materials, Industry Status and Trend

    Table 123. NK Cell Therapy Key Raw Materials and Upstream Suppliers

    Table 124. NK Cell Therapy Clients Status and Trend

    Table 125. NK Cell Therapy Typical Clients

    Table 126. NK Cell Therapy Distributors

    Table 127. NK Cell Therapy Market Trends

    Table 128. NK Cell Therapy Market Drivers

    Table 129. NK Cell Therapy Market Challenges

    Table 130. NK Cell Therapy Market Restraints

    Table 131. Research Programs/Design for This Report

    Table 132. Key Data Information from Secondary Sources

    Table 133. Key Data Information from Primary Sources

List of Figures

    Figure 1. NK Cell Therapy Product Picture

    Figure 2. Global NK Cell Therapy Revenue Market Share by Type in 2021 & 2028

    Figure 3. NK Cell Therapies Product Picture

    Figure 4. NK Cell Directed Antibodies Product Picture

    Figure 5. Global NK Cell Therapy Revenue Market Share by Application in 2021 & 2028

    Figure 6. Cancer

    Figure 7. Gastrointestinal Diseases

    Figure 8. Others

    Figure 9. NK Cell Therapy Report Years Considered

    Figure 10. Global NK Cell Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global NK Cell Therapy Market Size 2017-2028 (US$ Million)

    Figure 12. Global NK Cell Therapy Market Size Market Share by Region: 2022 Versus 2028

    Figure 13. Global NK Cell Therapy Revenue Market Share by Region (2017-2028)

    Figure 14. NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 15. Global NK Cell Therapy Revenue Market Share Forecast by Type (2017-2028)

    Figure 16. Global NK Cell Therapy Revenue Market Share Forecast by Application (2017-2028)

    Figure 17. North America NK Cell Therapy Revenue 2017-2028 (US$ Million)

    Figure 18. North America NK Cell Therapy Revenue Market Share by Type (2017-2022)

    Figure 19. North America NK Cell Therapy Revenue Market Share by Application (2017-2022)

    Figure 20. Asia-Pacific NK Cell Therapy Revenue 2017-2028 (US$ Million)

    Figure 21. Asia-Pacific NK Cell Therapy Revenue Market Share by Region (2017-2028)

    Figure 22. Asia-Pacific NK Cell Therapy Revenue Market Share by Type (2017-2022)

    Figure 23. Asia-Pacific NK Cell Therapy Revenue Market Share by Application (2017-2022)

    Figure 24. Europe NK Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 25. Europe NK Cell Therapy Revenue Market Share by Country (2017-2028)

    Figure 26. Europe NK Cell Therapy Revenue Market Share by Type (2017-2022)

    Figure 27. Europe NK Cell Therapy Revenue Market Share by Application (2017-2022)

    Figure 28. Latin America NK Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 29. Latin America NK Cell Therapy Revenue Market Share by Country (2017-2022)

    Figure 30. Latin America NK Cell Therapy Revenue Market Share by Type (2017-2022)

    Figure 31. Latin America NK Cell Therapy Revenue Market Share by Application (2017-2022)

    Figure 32. Middle East and Africa NK Cell Therapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 33. Middle East and Africa NK Cell Therapy Revenue Market Share by Country (2017-2028)

    Figure 34. Middle East and Africa NK Cell Therapy Revenue Market Share by Type (2017-2022)

    Figure 35. Middle East and Africa NK Cell Therapy Revenue Market Share by Application (2017-2022)

    Figure 36. NK Cell Therapy Supply Chain (Upstream and Downstream Market)

    Figure 37. Global Production Market Share of NK Cell Therapy Raw Materials by Region in 2021

    Figure 38. NK Cell Therapy Distribution Channels

    Figure 39. Global NK Cell Therapy Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 40. Global NK Cell Therapy Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 41. Bottom-up and Top-down Approaches for This Report

    Figure 42. Data Triangulation

    Figure 43. Key Executives Interviewed